Ongoing elimination efforts have altered the global distribution of Onchocerca volvulus, the agent of river blindness, and further population restructuring is expected as efforts continue. Therefore, ...
Moxidectin, a macrocyclic lactone, is an anthelmintic drug that selectively binds to the parasite's glutamate-gated chloride ion channels. The Food and Drug Administration (FDA) has approved ...
Despite decades of research, scientists have yet to pinpoint the exact cause of nodding syndrome (NS), a disabling disease affecting African children. A new report suggests that blackflies infected ...
image: The parasite that causes river blindness infects about 37 million people in parts of Africa and Latin America, causing blindness and other major eye and skin diseases in about 5 million of them ...
Recent reports of patients failing to respond to ivermectin, the standard drug for treating river blindness (onchocerciasis), have suggested the emergence of drug-resistant Onchocerca volvulus (the ...
An adult black fly with the parasite Onchocerca volvulus coming out of the insect’s antenna. United States Department of Agriculture, CC BY In sub-Saharan Africa and parts of Latin America, there is a ...
Scientists have for the first time fully sequenced the genome of onchocerca volvulus, the parasitic worm that causes river blindness. This has allowed them to identify a number of proteins that could ...
Onchocerciasis, also known as river blindness, is a disease that affects the skin and eyes. It’s caused by the worm Onchocerca volvulus. Onchocerca volvulus is a parasite. It’s spread to humans and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results